Literature DB >> 6128530

Control of acute Zollinger-Ellison syndrome with intravenous omeprazole.

A Blanchi, J C Delchier, J C Soule, D Payen, J P Bader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128530     DOI： 10.1016/s0140-6736(82)91246-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Use of omeprazole in patients with Zollinger-Ellison syndrome.

Authors:  H Frucht; P N Maton; R T Jensen
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 2.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 3.  Clinical pharmacology of omeprazole.

Authors:  C W Howden
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

4.  Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.

Authors:  C W Howden; J A Forrest; J L Reid
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

Review 5.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

6.  Effect of daily oral omeprazole on 24 hour intragastric acidity.

Authors:  R P Walt; M D Gomes; E C Wood; L H Logan; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

7.  Preformulation studies for generic omeprazole magnesium enteric coated tablets.

Authors:  C O Migoha; M Ratansi; E Kaale; G Kagashe
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

8.  Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

Authors:  E A Lew; J R Pisegna; J A Starr; E F Soffer; C Forsmark; I M Modlin; J H Walsh; M Beg; W Bochenek; D C Metz
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

9.  Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

Authors:  D C Metz; J R Pisegna; G L Ringham; K Feigenbaum; P D Koviack; P N Maton; J D Gardner; R T Jensen
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.